ASX - By Stock
|
WES |
Re:
News: WES Wesfarmers Says HY Net Profit Attributable Up 3.0% To A$1,425 Mln
|
|
Nydem
|
111 |
30K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
111
|
30K
|
1
|
|
ASX - By Stock
|
WES |
Re:
Ann: 2023 Strategy Briefing Day Presentation
|
|
Nydem
|
24 |
14K |
3 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
24
|
14K
|
3
|
|
ASX - By Stock
|
WES |
Re:
Ann: 2023 Strategy Briefing Day Presentation
|
|
Nydem
|
24 |
14K |
2 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
24
|
14K
|
2
|
|
ASX - By Stock
|
WES |
Re:
Ann: 2023 Strategy Briefing Day Presentation
|
|
Nydem
|
24 |
14K |
2 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
24
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Nydem
|
9.3K |
2.6M |
4 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
9.3K
|
2.6M
|
4
|
|
ASX - By Stock
|
WES |
Re:
overpriced falling knife.
|
|
Nydem
|
52 |
27K |
5 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
52
|
27K
|
5
|
|
ASX - By Stock
|
WES |
Re:
overpriced falling knife.
|
|
Nydem
|
52 |
27K |
5 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
52
|
27K
|
5
|
|
ASX - By Stock
|
COL |
Re:
News: COL Australia's Coles first-half profit jumps nearly 15%
|
|
Nydem
|
71 |
32K |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
71
|
32K
|
5
|
|
ASX - By Stock
|
WES |
Re:
overpriced falling knife.
|
|
Nydem
|
52 |
27K |
7 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
52
|
27K
|
7
|
|
ASX - By Stock
|
WES |
Re:
overpriced falling knife.
|
|
Nydem
|
52 |
27K |
2 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
52
|
27K
|
2
|
|
ASX - By Stock
|
WES |
Re:
overpriced falling knife.
|
|
Nydem
|
52 |
27K |
10 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
52
|
27K
|
10
|
|
ASX - By Stock
|
WES |
Re:
overpriced falling knife.
|
|
Nydem
|
52 |
27K |
13 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
52
|
27K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
4 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
4 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
1 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
3 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
4 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
13 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
17 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
2 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
4 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
12 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
1 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
5 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
11 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
19 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Nydem
|
9.3K |
2.6M |
6 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
9.3K
|
2.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
Nydem
|
811 |
330K |
13 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
811
|
330K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
Nydem
|
811 |
330K |
3 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
811
|
330K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
4 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Nydem
|
9.3K |
2.6M |
1 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
9.3K
|
2.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Nydem
|
9.3K |
2.6M |
7 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
9.3K
|
2.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Nydem
|
9.3K |
2.6M |
8 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
9.3K
|
2.6M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
Nydem
|
392 |
157K |
11 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
392
|
157K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
Nydem
|
392 |
157K |
14 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
392
|
157K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
2 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
6 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
6
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Strongly Supported Retail Entitlement Offer Completes
|
|
Nydem
|
54 |
19K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
54
|
19K
|
0
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Strongly Supported Retail Entitlement Offer Completes
|
|
Nydem
|
54 |
19K |
3 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
54
|
19K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
2 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
2 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
8 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
3 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Company Update - Webcast and Forward Thoughts
|
|
Nydem
|
273 |
127K |
9 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
273
|
127K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Company Update - Webcast and Forward Thoughts
|
|
Nydem
|
273 |
127K |
7 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
273
|
127K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Company Update - Webcast and Forward Thoughts
|
|
Nydem
|
273 |
127K |
17 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
273
|
127K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Nydem
|
555 |
265K |
9 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
265K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nydem
|
13K |
4.9M |
6 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Nydem
|
555 |
265K |
13 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
265K
|
13
|
|